Smoldering multiple myeloma: a multi-country mixed-methods study on disease perceptions and patient treatment preferences
Matthew Quaife, Cecilia Jimenez-Moreno, Blanca Gros Otero, Aisha Mariam Asra et autres
0 citationsFigshare
Bennett Levitan
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
126Publications signalées
2134Citations signalées
2Affiliations récentes
Institutions déclarées
Domaines associés
Health Systems, Economic Evaluations, Quality of LifePharmaceutical industry and healthcareAtrial Fibrillation Management and OutcomesPharmaceutical Economics and PolicyVenous Thromboembolism Diagnosis and Management
Publications récentes
Smoldering multiple myeloma: a multi-country mixed-methods study on disease perceptions and patient treatment preferences
Matthew Quaife, Cecilia Jimenez-Moreno, Blanca Gros Otero, Aisha Mariam Asra et autres
0 citationsFuture Oncology
Smoldering multiple myeloma: a multi-country mixed-methods study on disease perceptions and patient treatment preferences
Matthew Quaife, Cecilia Jimenez-Moreno, Blanca Gros Otero, Aisha Mariam Asra et autres
0 citationsFigshare
US Retina Specialists’ Preferences for Geographic Atrophy Treatment
Karl Csaky, Anthony Pepio, Caitlin Thomas, Bennett Levitan et autres
0 citationsClinical ophthalmology
Putting Patient Voices at the Heart of Healthcare Decisions: The UNIFIED Public-Private Project
Esther W. de Bekker-Grob, Jorien Veldwijk, Bianca Pop, Josh Coulter et autres
1 citationPatient
Caution is needed for systematic reviews and interpretation of preference studies
Jennifer A. Whitty, Brett Hauber, Josh Coulter, Juan Marcos Gonzalez et autres
0 citationsJournal of the European Academy of Dermatology and Venereology
Developing Tools for the Efficient Design of Health Preference Studies: Taxonomy of Attributes and Prototype of an Attribute Library
Norah L. Crossnohere, Jonah Golder, Esther W. de Bekker‐Grob, Juan Marcos González et autres
2 citationsPatient
Benefit–Risk Assessment of Rivaroxaban in Older Patients With Nonvalvular Atrial Fibrillation or Venous Thromboembolism
Paul P. Dobesh, Albert A. Volkl, Ákos F. Pap, C.V. Damaraju et autres
3 citationsDrugs & Aging
Quantitative Benefit–Risk Assessment of Vaccination Against COVID ‐19: A Systematic Review
E. Claire Newbern, Lea Wildisen, Rita Verstraeten, Corinne Willame et autres
0 citationsPharmacoepidemiology and Drug Safety
What Next for the Science of Patient Preference? Interoperability, Standardization, and Transferability
Kevin Marsh, Juan Marcos González, Conny Berlin, Bennett Levitan et autres
2 citationsPatient
First-Line Ibrutinib Plus Venetoclax Vs Chlorambucil Plus Obinutuzumab in Elderly or Comorbid Patients (Pts) with Chronic Lymphocytic Leukemia (CLL): Glow Study 64-Month Follow-up (FU) and Adverse Event (AE)-Free Progression-Free Survival (PFS) Analysis
Carsten Utoft Niemann, Talha Munir, Carolyn Owen, George Follows et autres
16 citationsBlood
PCR141 Smoldering Multiple Myeloma: A Multi-Country Mixed-Methods Study on Disease Perceptions and Patient Treatment Preferences
Matthew Quaife, Cecilia Jimenez‐Moreno, Gros Otero B, A Asra et autres
0 citationsValue in Health
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.